Rising Drug Patent Portfolio
Rising owns 1 orange book drug protected by 2 US patents Given below is the list of Rising's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status | 
|---|---|---|---|
| US7553835 | Topical antifungal composition | 19 Oct, 2018 | Expired | 
| US8026238 | Topical antifungal composition | 19 Oct, 2018 | Expired | 
Latest Legal Activities on Rising's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Rising.
| Activity | Date | Patent Number | 
|---|---|---|
|   | ||
| Expire Patent  Critical
                   | 30 Oct, 2023 | US8026238 | 
| Maintenance Fee Reminder Mailed  Critical
                   | 15 May, 2023 | US8026238 | 
| Payment of Maintenance Fee, 8th Year, Large Entity | 20 Mar, 2019 | US8026238 | 
| Change in Power of Attorney (May Include Associate POA)  Critical
                   | 14 Nov, 2016 | US8026238 | 
| Email Notification  Critical
                   | 14 Nov, 2016 | US8026238 | 
| Correspondence Address Change  Critical
                   | 10 Nov, 2016 | US8026238 | 
| Change in Power of Attorney (May Include Associate POA)  Critical
                   | 01 Oct, 2013 | US8026238 | 
| Email Notification  Critical
                   | 01 Oct, 2013 | US8026238 | 
| Correspondence Address Change  Critical
                   | 30 Sep, 2013 | US8026238 | 
| Patent Issue Date Used in PTA Calculation  Critical
                   | 27 Sep, 2011 | US8026238 | 
| Recordation of Patent Grant Mailed  Critical
                   | 27 Sep, 2011 | US8026238 | 
| Issue Notification Mailed  Critical
                   | 07 Sep, 2011 | US8026238 | 
| Dispatch to FDC | 26 Aug, 2011 | US8026238 | 
| Mail Response to 312 Amendment (PTO-271)  Critical
                   | 25 Aug, 2011 | US8026238 | 
| Response to Amendment under Rule 312  Critical
                   | 24 Aug, 2011 | US8026238 | 
Rising's Family Patents
 
 Rising Drug List
Given below is the complete list of Rising's drugs and the patents protecting them.
1. Extina
Extina is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status | 
|---|---|---|---|
| US7553835 | Topical antifungal composition | 19 Oct, 2018 
                  (7 years ago)
                 | Expired | 
| US8026238 | Topical antifungal composition | 19 Oct, 2018 
                  (7 years ago)
                 | Expired | 
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Extina's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
 
                  Explore the top-performing drugs that dominate the pharmaceutical industry
                
View List
NCE-1 Patent Expiry in the Next 1 Year
 
                  Identify opportunities as new chemical entity (NCE-1) patents approach expiry
                
View List
Recently Granted Patents in EP
 
                  Find the opportunity to file Oppositions
                
View List
